IBDEI1YT ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=SCREENING^22^11
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=CHEST PAIN^3^11
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=CORONARY ATHEROSCLEROSIS^6^11
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=OTHER FORMS OF HEART DISEASE^18^11
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=HYPERTENSION^11^11
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=NONRHEUMATIC HEART VALVE DISEASE^16^11
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=RHEUMATIC HEART DISEASE^21^11
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=COMPLICATIONS^5^11
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=HISTORY CODES^10^11
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=OTHER CONDITIONS^17^11
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=RESEARCH/CLINICAL TRIALS^20^11
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=BLINDNESS^2^11
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=CVA LATE EFFECTS^7^11
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=HEPATITIS^9^11
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=MENTAL HEALTH^14^11
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=SPINAL CORD INJURY^23^11
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=NEW PATIENT^2^12
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=ESTABLISHED PATIENT^1^12
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=CONSULTATIONS^3^12
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=SCREENING FOR MENTAL/DEVELOPMENT^6^13
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=PERSONS SEEKING CONSULT^5^13
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=FAMILY CIRCUMSTANCES^2^13
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=MENTAL AND BEHAVIORAL PROBLEMS^4^13
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=ADMINISTRATIVE PURPOSES^1^13
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=HOUSING & ECONOMIC CIRCUMSTANCES^3^13
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=TEAM CONFERENCE^3^14
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=SOCIAL WORKER^2^14
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=PSYCH^1^14
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=CLINICIAN^1^15
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=NEW PATIENT^2^16
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=ESTABLISHED PATIENT^1^16
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=CONSULTATIONS^3^16
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^3^17
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=HEADACHE & MIGRAINE^1^17
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=DORSOPATHIES & JOINT DISORDERS^2^17
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=OSTHEOP,CHRONDROP,ACQ MS DEFORM^4^17
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=PAIN & OTH SYMPTOMS^5^17
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=PERIPHERAL NERVOUS SYSTEM DISORDERS^6^17
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=RHEUMATISM^7^17
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=SPINAL & INTERVERTEBRAL DISC DISORDERS^8^17
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=SPRAINS & STRAINS^9^17
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=MISCELLANEOUS TREATMENT^4^18
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^18
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^18
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=ACUPUNCTURE^1^18
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=EDUCATION FOR SELF MGT^3^18
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=SUBSEQUENT NRSG FACILITY CARE^2^19
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=INITIAL NRSG FACILITY CARE^1^19
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=INPT-CONSULTATIONS^3^19
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=DISCHARGE DAY VISIT^6^19
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=OTH NURSG FACILITY SVCS^4^19
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=TRANSITIONAL CARE^5^19
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=INPT VENT MGMT^2^20
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=ASSESSMENT^1^20
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=PROLONGED SERVICES^3^20
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=CARDIOVASCULAR^3^21
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=RESPIRATORY^19^21
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=MUSCULOSKELETAL^15^21
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=NEURO^16^21
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=GASTROENTEROLOGY^8^21
